| 注册
首页|期刊导航|肿瘤预防与治疗|中国癌症机会性筛查实施进展与展望

中国癌症机会性筛查实施进展与展望

董学思 李霓 赫捷

肿瘤预防与治疗2025,Vol.38Issue(2):93-97,5.
肿瘤预防与治疗2025,Vol.38Issue(2):93-97,5.DOI:10.3969/j.issn.1674-0904.2025.02.001

中国癌症机会性筛查实施进展与展望

Progress and Prospect of Opportunistic Cancer Screening in China

董学思 1李霓 1赫捷1

作者信息

  • 1. 100021 北京,国家癌症中心/国家恶性肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院 癌症早诊早治办公室
  • 折叠

摘要

Abstract

In response to the heavy cancer burden in China,implementing opportunistic cancer screening and expanding its coverage are effective strategies for current cancer prevention and control.Existing evidence reveals that opportunistic screen-ing offers potential favorable biological outcomes and economic benefits with broad application prospects,serving as an impor-tant supplement to organized screening programs.This review focuses on the implementation progress of opportunistic screen-ing in China,proposes outlook for optimizing current screening practice,and provides scientific evidence and practical guid-ance for the implementation of opportunistic screening.

关键词

健康中国/癌症筛查/机会性筛查

Key words

Healthy China/Cancer screening/Opportunistic screening

分类

医药卫生

引用本文复制引用

董学思,李霓,赫捷..中国癌症机会性筛查实施进展与展望[J].肿瘤预防与治疗,2025,38(2):93-97,5.

基金项目

国家自然科学基金(编号:82404340、82273722) (编号:82404340、82273722)

中国医学科学院医学与健康科技创新工程(编号:2021-I2M-1-067) (编号:2021-I2M-1-067)

北京协和医学院协和青年科研基金(编号:3332024216) This study was supported by National Natural Science Foundation of China(No.82404340,No.82273722),by grants from Chinese Academy of Medical Sciences(No.2021-I2M-1-067)and PUMC(No.3332024216). (编号:3332024216)

肿瘤预防与治疗

1674-0904

访问量5
|
下载量0
段落导航相关论文